vs
安进（AMGN）与Ross Stores（ROST）财务数据对比。点击上方公司名可切换其他公司
安进的季度营收约是Ross Stores的1.8倍（$9.9B vs $5.6B），安进净利率更高（13.5% vs 9.1%，领先4.4%），Ross Stores同比增速更快（10.4% vs 8.6%），安进自由现金流更多（$961.0M vs $617.8M），过去两年安进的营收复合增速更高（15.1% vs -3.6%）
安进是总部位于美国加利福尼亚州千橡市的跨国生物制药企业，公司名称取自最初的全称「应用分子遗传学」的缩写组合，按营收规模排名位列全球生物医药企业第18位，专注于研发、生产及商业化创新生物药物，为全球患者提供优质治疗选择。
Ross Stores, Inc.是美国知名折扣百货连锁集团，旗下核心品牌为Ross Dress for Less，总部位于加利福尼亚州都柏林，是美国规模最大的平价零售商。截至2024年7月，集团在全美43个州、华盛顿特区、波多黎各及关岛共运营1795家门店，暂未覆盖新英格兰地区及阿拉斯加，另拥有门店数超353家的折扣零售品牌DD's Discounts。
AMGN vs ROST — 直观对比
营收规模更大
AMGN
是对方的1.8倍
$5.6B
营收增速更快
ROST
高出1.9%
8.6%
净利率更高
AMGN
高出4.4%
9.1%
自由现金流更多
AMGN
多$343.2M
$617.8M
两年增速更快
AMGN
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.9B | $5.6B |
| 净利润 | $1.3B | $511.9M |
| 毛利率 | 69.8% | 28.0% |
| 营业利润率 | 27.6% | 11.6% |
| 净利率 | 13.5% | 9.1% |
| 营收同比 | 8.6% | 10.4% |
| 净利润同比 | 112.6% | 4.7% |
| 每股收益（稀释后） | $2.45 | $1.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMGNROST
| Q4 25 | $9.9B | $5.6B | ||
| Q3 25 | $9.6B | $5.5B | ||
| Q2 25 | $9.2B | $5.0B | ||
| Q1 25 | $8.1B | $5.9B | ||
| Q4 24 | $9.1B | $5.1B | ||
| Q3 24 | $8.5B | $5.3B | ||
| Q2 24 | $8.4B | $4.9B | ||
| Q1 24 | $7.4B | $6.0B |
净利润AMGNROST
| Q4 25 | $1.3B | $511.9M | ||
| Q3 25 | $3.2B | $508.0M | ||
| Q2 25 | $1.4B | $479.2M | ||
| Q1 25 | $1.7B | $586.8M | ||
| Q4 24 | $627.0M | $488.8M | ||
| Q3 24 | $2.8B | $527.1M | ||
| Q2 24 | $746.0M | $488.0M | ||
| Q1 24 | $-113.0M | $609.7M |
毛利率AMGNROST
| Q4 25 | 69.8% | 28.0% | ||
| Q3 25 | 67.8% | 27.6% | ||
| Q2 25 | 67.2% | 28.2% | ||
| Q1 25 | 63.6% | 26.5% | ||
| Q4 24 | 65.7% | 28.3% | ||
| Q3 24 | 61.1% | 28.3% | ||
| Q2 24 | 61.4% | 28.1% | ||
| Q1 24 | 57.0% | 27.3% |
营业利润率AMGNROST
| Q4 25 | 27.6% | 11.6% | ||
| Q3 25 | 26.4% | 11.5% | ||
| Q2 25 | 28.9% | 12.2% | ||
| Q1 25 | 14.5% | 12.4% | ||
| Q4 24 | 25.4% | 11.9% | ||
| Q3 24 | 24.1% | 12.5% | ||
| Q2 24 | 22.8% | 12.2% | ||
| Q1 24 | 13.3% | 13.2% |
净利率AMGNROST
| Q4 25 | 13.5% | 9.1% | ||
| Q3 25 | 33.7% | 9.2% | ||
| Q2 25 | 15.6% | 9.6% | ||
| Q1 25 | 21.2% | 9.9% | ||
| Q4 24 | 6.9% | 9.6% | ||
| Q3 24 | 33.3% | 10.0% | ||
| Q2 24 | 8.9% | 10.0% | ||
| Q1 24 | -1.5% | 10.1% |
每股收益（稀释后）AMGNROST
| Q4 25 | $2.45 | $1.58 | ||
| Q3 25 | $5.93 | $1.56 | ||
| Q2 25 | $2.65 | $1.47 | ||
| Q1 25 | $3.20 | $1.79 | ||
| Q4 24 | $1.17 | $1.48 | ||
| Q3 24 | $5.22 | $1.59 | ||
| Q2 24 | $1.38 | $1.46 | ||
| Q1 24 | $-0.21 | $1.82 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.1B | $4.1B |
| 总债务越低越好 | $54.6B | $1.5B |
| 股东权益账面价值 | $8.7B | $5.9B |
| 总资产 | $90.6B | $15.4B |
| 负债/权益比越低杠杆越低 | 6.31× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资AMGNROST
| Q4 25 | $9.1B | $4.1B | ||
| Q3 25 | $9.4B | $3.8B | ||
| Q2 25 | $8.0B | $3.8B | ||
| Q1 25 | $8.8B | $4.7B | ||
| Q4 24 | $12.0B | $4.3B | ||
| Q3 24 | $9.0B | $4.7B | ||
| Q2 24 | $9.3B | $4.7B | ||
| Q1 24 | $9.7B | $4.9B |
总债务AMGNROST
| Q4 25 | $54.6B | $1.5B | ||
| Q3 25 | $54.6B | $1.5B | ||
| Q2 25 | $56.2B | $1.5B | ||
| Q1 25 | $57.4B | $2.2B | ||
| Q4 24 | $60.1B | $2.2B | ||
| Q3 24 | $60.4B | $2.5B | ||
| Q2 24 | $62.6B | $2.5B | ||
| Q1 24 | $64.0B | $2.5B |
股东权益AMGNROST
| Q4 25 | $8.7B | $5.9B | ||
| Q3 25 | $9.6B | $5.7B | ||
| Q2 25 | $7.4B | $5.6B | ||
| Q1 25 | $6.2B | $5.5B | ||
| Q4 24 | $5.9B | $5.3B | ||
| Q3 24 | $7.5B | $5.1B | ||
| Q2 24 | $5.9B | $4.9B | ||
| Q1 24 | $5.0B | $4.9B |
总资产AMGNROST
| Q4 25 | $90.6B | $15.4B | ||
| Q3 25 | $90.1B | $14.5B | ||
| Q2 25 | $87.9B | $14.3B | ||
| Q1 25 | $89.4B | $14.9B | ||
| Q4 24 | $91.8B | $14.9B | ||
| Q3 24 | $90.9B | $14.7B | ||
| Q2 24 | $90.9B | $14.5B | ||
| Q1 24 | $93.0B | $14.3B |
负债/权益比AMGNROST
| Q4 25 | 6.31× | 0.26× | ||
| Q3 25 | 5.67× | 0.26× | ||
| Q2 25 | 7.57× | 0.27× | ||
| Q1 25 | 9.24× | 0.40× | ||
| Q4 24 | 10.23× | 0.42× | ||
| Q3 24 | 8.02× | 0.48× | ||
| Q2 24 | 10.57× | 0.50× | ||
| Q1 24 | 12.75× | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.6B | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $961.0M | $617.8M |
| 自由现金流率自由现金流/营收 | 9.7% | 11.0% |
| 资本支出强度资本支出/营收 | 6.5% | 3.7% |
| 现金转化率经营现金流/净利润 | 1.20× | 1.62× |
| 过去12个月自由现金流最近4个季度 | $8.1B | $2.0B |
8季度趋势，按日历期对齐
经营现金流AMGNROST
| Q4 25 | $1.6B | $827.1M | ||
| Q3 25 | $4.7B | $668.4M | ||
| Q2 25 | $2.3B | $409.7M | ||
| Q1 25 | $1.4B | $882.6M | ||
| Q4 24 | $4.8B | $513.4M | ||
| Q3 24 | $3.6B | $592.1M | ||
| Q2 24 | $2.5B | $368.9M | ||
| Q1 24 | $689.0M | $948.8M |
自由现金流AMGNROST
| Q4 25 | $961.0M | $617.8M | ||
| Q3 25 | $4.2B | $466.6M | ||
| Q2 25 | $1.9B | $202.3M | ||
| Q1 25 | $980.0M | $676.6M | ||
| Q4 24 | $4.4B | $333.0M | ||
| Q3 24 | $3.3B | $394.6M | ||
| Q2 24 | $2.2B | $232.7M | ||
| Q1 24 | $459.0M | $726.4M |
自由现金流率AMGNROST
| Q4 25 | 9.7% | 11.0% | ||
| Q3 25 | 44.4% | 8.4% | ||
| Q2 25 | 20.8% | 4.1% | ||
| Q1 25 | 12.0% | 11.4% | ||
| Q4 24 | 48.4% | 6.6% | ||
| Q3 24 | 39.0% | 7.5% | ||
| Q2 24 | 26.5% | 4.8% | ||
| Q1 24 | 6.2% | 12.1% |
资本支出强度AMGNROST
| Q4 25 | 6.5% | 3.7% | ||
| Q3 25 | 4.6% | 3.6% | ||
| Q2 25 | 4.0% | 4.2% | ||
| Q1 25 | 5.0% | 3.5% | ||
| Q4 24 | 4.1% | 3.6% | ||
| Q3 24 | 3.0% | 3.7% | ||
| Q2 24 | 2.8% | 2.8% | ||
| Q1 24 | 3.1% | 3.7% |
现金转化率AMGNROST
| Q4 25 | 1.20× | 1.62× | ||
| Q3 25 | 1.46× | 1.32× | ||
| Q2 25 | 1.59× | 0.85× | ||
| Q1 25 | 0.80× | 1.50× | ||
| Q4 24 | 7.61× | 1.05× | ||
| Q3 24 | 1.26× | 1.12× | ||
| Q2 24 | 3.30× | 0.76× | ||
| Q1 24 | — | 1.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMGN
| Products | $9.4B | 95% |
| Xgeva | $291.0M | 3% |
| Vectibix | $163.0M | 2% |
| Aranesp | $115.0M | 1% |
ROST
暂无分部数据
